J & E Davy (UK) Limited Form 38.5a UDG Healthcare plc (8247C)
June 23 2021 - 2:42AM
UK Regulatory
TIDMUDG
RNS Number : 8247C
J & E Davy (UK) Limited
23 June 2021
Ap24
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED
INTERMEDIARY STATUS AND DEALING IN A
CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal J&E Davy (UK) Limited
trader
Company dealt in UDG Healthcare plc
=====================
Class of relevant security Ordinary Shares
to which the dealings
being disclosed relate
(Note 1)
=====================
Date of dealing 22 June 2021
=====================
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number Highest price paid Lowest price
of relevant (Note 3) paid
securities acquired (Note 3)
202,675 1041.25 GBX 1038.25 GBX
========================= ===============
Total number Highest price received Lowest price
of securities (Note 3) received
disposed (Note 3)
257,022 1045.58.05 GBX 1038.25 GBX
============================= ===============
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 4) securities unit
e.g. CFD (Note 5) (Note 3)
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 3)
etc. relates (Note
5)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
3)
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If
none, this should be stated.
Date of disclosure 23 June 2021
Contact name Irina Drozan
============================
Telephone number +353 1 614 8923
============================
Name of offeree/offeror UDG Healthcare plc
with which connected
============================
Nature of connection (Note Concert Party to the Offeree
6)
============================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ISEEAXKDADNFEEA
(END) Dow Jones Newswires
June 23, 2021 03:42 ET (07:42 GMT)
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2024 to May 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From May 2023 to May 2024